Synthesis of BF2chelates of tetraarylazadipyrromethenes and evidence for their photodynamic therapeutic behaviour
Chemical Communications2002Iss. 17, pp. 1862–1863
Citations Over TimeTop 10% of 2002 papers
Abstract
The synthesis, spectroscopic characteristics and in vitro cellular uptake properties of a new class of therapeutic window photosensitiser, namely the BF2 chelates of 3,5-diaryl-1H-pyrrol-2-yl-3,5-diarylpyrrol-2-ylidene amines (tetra-arylazadipyrromethenes), are described with the aim of developing a novel class of photodynamic therapeutic agents.
Related Papers
- → Therapeutic drug monitoring(2013)8 cited
- → Including Information on the Therapeutic Window in Bioequivalence Acceptance(2008)3 cited
- → Neuroleptic Plasma Concentrations and Clinical Response: In Search of a Therapeutic Window(1988)11 cited
- → Therapeutic drug monitoring(2016)1 cited
- Safety consideration on the conversion of tacrolimus formulations(2012)